Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Praxis

‘We can’t go back’: mother of six-year-old cancer survivor fears UK visa changes

Woman, from west Africa, faces uncertain wait for indefinite leave to remain because of changes coming into force next month

The Guardian - UK

Nurses’ families fear being torn apart in UK immigration crackdown, survey says

Exclusive: Most people in charity’s study say they worry about being separated from relatives under Mahmood plans

The Guardian - UK

The Trump doctrine exposes the US as a mafia state

The Venezuela incursion is in line with this logic, made even plainer as the US eyes Greenland

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Canyon Endurace:ONfly CF 8 review: an e-bike that feels like a tailwind, at last

The promise of e-bikes was an easier ride, but with strict limits on the intervention from the motor, they’ve struggled to find relevance in the road category - this new TQ-equipped Endurace moves that dial.

Cycling Weekly

Praxis' Epilepsy Drug Too Good To Continue, FDA Meeting Up Next

Praxis Precision Medicines Inc. (NASDAQ:PRAX) stock rose Friday after the company shared results from the registrational cohort of the EMBOLD study evaluating relutrigine for the treatment of patients with SCN2A and SCN8A developmental and epileptic encephalopathies (DEEs).

Benzinga

Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards'

A short seller is challenging Praxis Precision Medicines Inc. (NASDAQ:PRAX) after the company claimed success from its Phase 3 trial of ulixacaltamide.

Benzinga

This ‘Strong Buy’ Stock Has More Than Tripled Today. Should You Buy It Here?

Praxis shares soar as the biotech firm reports promising late-stage results for ulixacaltamide. Here’s why it may not be too late to invest in PRAX shares.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Praxis Precision Medicines Stock Doubles - Here's Why

Praxis Precision Medicines Inc. (NASDAQ:PRAX) stock skyrocketed on Thursday.

Benzinga

NHS could cease to function under Labour’s new visa rules, say nurses

Exclusive: Royal College of Nursing says plan to tighten rules for foreign workers is ‘pandering’ to Reform UK

The Guardian - UK

Praxis' Epilepsy Treatment Shows Promise With Decreased Seizures

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) stock experienced a volatile trading session on Monday, after the company announced positive topline results from its Phase 2 RADIANT study evaluating vormatrigine in patients with focal onset seizures and generalized epilepsy.

Benzinga

Refugee charities demand meeting with Yvette Cooper after sweeping changes to immigration rules

Exclusive: More than 100 charities and civil society groups call for ‘meaningful dialogue’ with home secretary after tough new immigration plans unveiled

The Independent UK

Tech moguls who invested in Greenland mining also gave Trump campaign $243m: report

Troubling links tie tech money to both Greenland and Trump. The tech industry desperately needs the rare earth minerals on the island, while Trump repeatedly threatens to take over the territory

The Independent UK

Trump donors eye potential bonanza if US succeeds with Greenland land-grab

Ethical doubts over role of campaign backers and investors with financial ties to president worth hundreds of millions

The Guardian - US

Migrants and refugee families in the UK denied childcare funding, report finds

Immigration status is denying children equal access to early years education and pushing families ‘deeper into poverty’

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Eight all-time great Christmas cookbooks to see you through till New Year

From Delia to Nigella, and the River Cafe to the Pie Room, here are the best cookbooks to see you through Christmas

The Independent UK

Charities sound alarm over migrant parents being denied vital childcare

Many working parents of children who are British citizens are blocked from accessing extended free childcare due to their immigration status.

Evening Standard

'I feel illegal in this country': Thousands of parents of British children wait 12 months for visas

Visas for around 170,000 people, including parents of British children, are taking a year to process

Bike Perfect

Pivot teams up with Bosch to power their new sleeker Shuttle AM e-MTB

Pivot's Shuttle AM e-MTB is their first Bosch-powered e-MTB and claims to be ready to tackle any trail on the mountain

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Windrush victim who became homeless says compensation fight ‘worse than hell’

Speaking ahead of 75th Windrush anniversary, Fitzroy Maynard tells how he lost his home after being unable to prove he had the right to work

The Independent UK

Father who became homeless describes Windrush experience as ‘worse than hell’

Fitzroy Maynard said he is determined to fight for what he is entitled to and insisted anyone using the compensation scheme needs legal support.

TechRadar

Intel Core i7-13700K review: Raptor Lake for the midrange

The Intel Core i7-13700K is a fantastic processor with outstanding performance across the board for an even better price, though its power efficiency leaves much to be desired.

Bike Perfect

Giant's new Trance X Advanced E+ Elite is their lightest e-MTB ever, but it still packs full-power

Giant enters the lightweight e-MTB with their full-power Trance X Advanced E+ Elite and it's loaded with tech

The Independent UK

Revealed: The true toll of ‘punishing’ 10-year process endured by thousands wanting to settle in the UK

‘This is no way to treat people who have made, and will continue to make, their lives in the UK’

Daily Mirror

Refugees scared to visit GP or look for flats as Tories made UK a hostile nation

Sally Daghlian OBE, Praxis CEO, says her charity for migrants and refugees sees the 'human cost' of the hostile environment created by the Conservative Party every single day

Benzinga

Praxis' PRAX-944 Shows Promising Action In Essential Tremor Patients

Praxis Precision Medicines Inc (NASDAQ:PRAX) announced topline results from Part B of its Phase 2a study evaluating the safety and efficacy of PRAX-944 for essential tremor (ET). Treatment with PRAX-944 resulted in clinically meaningful improvements in function, supported by improvements in tremor amplitude. In the open-label period through Day 42, patients treated with…

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations